In this study, both human and canine OS cells showed greater sensitivity to treatment with HDAC inhibitors compared to normal canine osteoblasts, suggesting tumor cell specific anti-apoptotic effects of HDAC inhibition. The gene discussed is HDAC9; the disease is neoplasm.